Lars S. Maier

Active 1998–2025

173
Papers
21,151
Citations
82
h-index
161
i10-index

Citations

Citations per year for Lars S. Maier1991: 1 citations1999: 3 citations2000: 24 citations2001: 15 citations2002: 30 citations2003: 56 citations2004: 75 citations2005: 57 citations2006: 106 citations2007: 113 citations2008: 124 citations2009: 176 citations2010: 199 citations2011: 202 citations2012: 172 citations2013: 201 citations2014: 244 citations2015: 186 citations2016: 139 citations2017: 140 citations2018: 173 citations2019: 559 citations2020: 804 citations2021: 760 citations2022: 614 citations2023: 485 citations2024: 780 citations2025: 399 citations2026: 10 citations1992–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,995 citing papers, 22.6% of this breakdownGermany: 999 citing papers, 11.3% of this breakdownChina: 724 citing papers, 8.2% of this breakdownUnited Kingdom: 615 citing papers, 7% of this breakdownItaly: 515 citing papers, 5.8% of this breakdownNetherlands: 361 citing papers, 4.1% of this breakdownCanada: 341 citing papers, 3.9% of this breakdownFrance: 288 citing papers, 3.3% of this breakdownJapan: 208 citing papers, 2.4% of this breakdownSpain: 190 citing papers, 2.1% of this breakdownSwitzerland: 165 citing papers, 1.9% of this breakdownAustralia: 151 citing papers, 1.7% of this breakdown
0%22.6%Other 25.7%

Fields

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology23.1%
  • Engineering6.6%
  • Neuroscience2.2%
  • Immunology and Microbiology0.6%
  • Computer Science0.3%
  • Other1.4%

Topics

  • Cardiac electrophysiology and arrhythmias8%
  • Cardiovascular Function and Risk Factors4.6%
  • Ion channel regulation and function4.6%
  • Cardiomyopathy and Myosin Studies3.3%
  • Pluripotent Stem Cells Research2.8%
  • Mechanical Circulatory Support Devices2.7%
  • Other74%

Coauthors

All papers

Open in search
  1. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,172

  2. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2020 cited by 316

  3. Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Çhristof Schmid, Hölger Thiele, Raphael Twerenbold, Thomas Walther, Dirk Westermann, Erion Xhepa, Andreas Ziegler, Volkmar Falk - New England Journal of Medicine 2024 cited by 226

  4. DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ederlon Rezende, Caio Vinicius Gouvêa Jaoude, Ellen Pierre de Olivera, Vania Quinato Malacize, Claudio Stadnik, Eduarda Annoni Ramos, Graziela Regina Kist, Gynara Rezende Barbosa, Henrique Filik, Sabrina Nalin, Charlotte Suppli Ulrik, Casper Tidemandsen, Kjell Erik Julius Håkansson, Thomas Benfield, Karen Brorup Pedersen, Tobias Welte, Marcus Bachman, Mathias Stoll, Ilona Olzik, Natascha Scharf, Nicole Shearman, Isabell Pink, Anna Frey, Petra Schulze, Cyrus Sayehli, Dirk Weismann, Hartwig Klinker, Maria-Elisabeth Goebeler, Lars S. Maier, Florian Geismann, Frank Hanses, Judith Zeller, Julian Hupf, Matthias Lubnow, Sabine Sag, Sarah Ripfel, Steffen Pabel, Stilla Bauernfeind, Ulf Leisner, Florian Hitzenbichler, Ildikó Madurka, Dora Iharos, Krisztina Kormosoi Toth, Maria Hejja, Tamas Esze, Sushma Bhatnagar, Anant Mohan, Anuja Pandit, Balbir Kumar, Brajesh Kumar Ratre, Pawan Tiwari, Ram Singh, Saurabh Vig, Shweta Bhopale, S. Bhan, Akshay Budhraja, Ankit Agrawal, Srikanth V. Krishnamurthy, Ambika Srikanth, Kalaiyamishan Kaneesan, Mauila Raghavan Jaymohan Unnithan, Nagarajan Srinivasan, Nandagopal Velayuthaswamy, Senthil Kumar Mothu Gounder, Venkatraman Vaidyanathan, Amitabha Saha, Abhishek Bhattacharjee, Avijatri Datta, Adrián Rendón, Adrián Camacho Ortiz and 71 more - Infection 2022 cited by 83

  5. One-Year Outcomes after PCI Strategies in Cardiogenic Shock

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steffen Schneider, Uwe Zeymer, Steffen Desch - New England Journal of Medicine 2018 cited by 431

  6. Empagliflozin Reduces Ca/Calmodulin-Dependent Kinase II Activity in Isolated Ventricular Cardiomyocytes

    Authors: , , , , , , , , , , , , , , , , , , , - ESC Heart Failure 2018 cited by 236

  7. Oxidized Ca 2+ /Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2013 cited by 313

  8. Empagliflozin Directly Improves Diastolic Function in Human Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2018 cited by 220

  9. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michał Kowara, Bartosz Rymuza, Mariusz Kłopotowski, Łukasz A. Małek, Dániel Aradi, Gábor Veress, András Döme Dézsi, Béla Merkely, Árpád Lux, Róbert Gábor Kiss, Judit Papp, Andrea Kovács, Csaba András Dézsi, Sayour Amer, Zoltán Ruzsa, Szilárd Róna, András Komócsi, Renáta Ili, Imre Ungi, Ferenc Nagy, Robert Zweiker, Gábor Tóth-Gayor, Kurt Huber, Paul M. Haller, Wolfgang von Scheidt, A. Blüthgen, Franz‐Josef Neumann, Dietmar Trenk, Stefan Leggewie, Hans Ulrich Kreider-Stempfle, T. Remp, Kaffer Kara, Andreas Mügge, Alexander Wutzler, Stephan Fichtlscherer, Andreas M. Zeiher, Florian Seeger, Martin Hinterseer, Andreas König, Susanne Lederle, Claudius Jacobshagen, Frauke Czepluch, Lars S. Maier, Wolfgang Schillinger, Samuel Sossalla, Astrid Hummel, Stephan B. Felix, Mahir Karakas, Karsten Sydow, Tanja K. Rudolph, Marcel Halbach, Tommaso Gori, Thomas Münzel, Andreas E. May, Carsten-Manuel Gerstenberg, Dávid Pilecky, Johannes Rieber, Markus Deichstetter, Dirk Sibbing, Julinda Mehilli, Lisa Groß, Stefan Kääb, Anja Löw, Martin Orban, Matthias Orban, Stefan M. Sattler, Sabine Deuschl, Daniel Teupser, Lesca M. Holdt, Harald Mudra and 14 more - The Lancet 2017 cited by 590

  10. Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen J. Bax, Frank Ruschitzka, Jelena-Rima Ghadri, Joachim M. Buhmann, Christian Templin - JAMA Cardiology 2022 cited by 74

  11. Empagliflozin Inhibits Na+/H+ Exchanger Activity in Human Atrial Cardiomyocytes

    Authors: , , , , , , , , - ESC Heart Failure 2020 cited by 112

  12. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial

    Authors: , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 366

  13. Effects of Atrial Fibrillation on the Human Ventricle

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Research 2022 cited by 82

  14. Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II

    Authors: , , , , , , , , , , , - Circulation 2022 cited by 50

  15. A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Freichel, Hermann‐Josef Gröne, Patrick Most, Oliver J. Müller, Stephan Herzig, Eileen E. M. Furlong, Hugo A. Katus, Johannes Backs - Nature Medicine 2017 cited by 137

  16. The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 433

  17. CaMKII-Dependent Diastolic SR Ca 2+ Leak and Elevated Diastolic Ca 2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation

    Authors: , , , , , , , , , - Circulation Research 2010 cited by 408

  18. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2006 cited by 554

  19. Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study

    Authors: , , , , , , , , , , , - European Heart Journal 2024 cited by 58

  20. The δ C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure

    Authors: , , , , , , - Circulation Research 2003 cited by 561

  21. Cardiac fibroblasts support cardiac inflammation in heart failure

    Authors: , , , , , , , , , , , - Basic Research in Cardiology 2014 cited by 162

  22. Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 78

  23. Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 cited by 83

  24. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis

    Authors: , , , , , , , , , , - Cardiovascular Research 2015 cited by 148